Scientists at Fred Hutch Cancer Center and Seattle Children's Hospital have a new vision for cancer's origins. They argue ...

Vanessa Osorio Laughlin has noticed a perk of giving monthly to Fred Hutch Cancer Center — she gets thanked twelve times a year. Thirteen, if you count the acknowledgment letter at tax time.

Two Fred Hutch Cancer Center researchers received prestigious R01 awards to support large projects with clear outcomes and ...

University of Washington biochemist Vera Trainer, PhD, learned she had ovarian cancer at the height of her scientific career.

Rahul Banerjee, MD, FACP joins Petros Grivas, MD, PhD to discuss how CAR T cell-therapy and bispecific antibodies are changing myeloma care, ongoing Fred Hutch trials, working with community ...

Three Fred Hutch scientists received research grants from the American Cancer Society to study how mutations in cell metabolism can lead to different types of cancer in different tissue types, how a ...

A Nature study reveals that a single transfer RNA (tRNA) helps determine whether prostate cancer remains treatment-sensitive or becomes resistant, opening new avenues in precision oncology SEATTLE — ...

Two Fred Hutch Cancer Center scientists received prestigious R01 awards to support development of biomarkers for disease diagnosis and risk detection. You will receive a monthly newsletter from us ...

Blood and marrow transplantation, or BMT, for blood cancers is a medical miracle, but it comes with significant risks. Fred Hutch hematologist Marco Mielcarek, MD, PhD, has received a five-year, $3.5 ...

When Alaura Keith was diagnosed with triple-negative breast cancer in 2013, every physician she saw suggested a different treatment. “None of them could agree on what do to,” she said.

Oncology Insights: Dr. Petros Grivas sits down with Dr. Molly Tokaz to discuss thoracic oncology and the unique clinical and research partnerships connecting Fred Hutch Cancer Center, UW Medicine, ...

Many cultures tell stories about shapeshifters: gods becoming animals, animals becoming humans, demons switching into forms both beguiling and terrifying. In the past six years, cancer biologists at ...